PATENTED INGREDIENT
AstaReal® Natural Astaxanthin (from Microalgae)
AstaReal® Natural Astaxanthin (from Microalgae) is a patented ingredient in the ACC Biotech catalogue, developed by AstaReal Co., Ltd., with Japan listed as its origin. This page brings together the ingredient information currently available from ACC Biotech and the enquiry route.

INGREDIENT PROFILE
What this ingredient is documented for
- Origin
- Japan
- Developer
- AstaReal Co., Ltd.
- Natural astaxanthin produced by AstaReal (Fuji Chemical Industries, Japan) from Haematococcus pluvialis microalgae
- One of nature's most powerful antioxidants — helps neutralize free radicals and supports skin, eye and cardiovascular health
- In sports nutrition, supports muscle endurance and post-exercise recovery
- Over 35 years of research and 85+ clinical studies, delivering the highest grade of natural astaxanthin
- Cultivated in a clean, indoor system for consistent quality; natural (non-synthetic) astaxanthin
QUICK REFERENCE
Key ingredient facts
- Origin
- Japan
- Developer
- AstaReal Co., Ltd.
About AstaReal® Natural Astaxanthin (from Microalgae)
AstaReal® Natural Astaxanthin (from Microalgae) is a patented ingredient in the ACC Biotech catalogue, developed by AstaReal Co., Ltd., with Japan listed as its origin. This page brings together the ingredient information currently available from ACC Biotech and the enquiry route.
Frequently asked questions
These answers summarize ACC Biotech's current catalogue information and enquiry process.
What information is available for AstaReal® Natural Astaxanthin (from Microalgae)?
This page summarizes the ingredient highlights, origin and developer information currently held in the ACC Biotech catalogue.
How can I request formulation, documentation or sourcing details?
Contact ACC Biotech with the intended dosage form, market and document requirements so the team can follow up with the relevant information.
FORMULATION
Discuss this ingredient with ACC
Bring this ingredient into a formula, documentation and sourcing conversation with the ACC team.



